Therapeutic Depth: Allergy

Decades of Experience in Allergy & Asthma Studies

Therapeutic Depth: Allergy

Allergic diseases, including asthma, make up the sixth leading chronic disease in the U.S.1

With changes in the start and length of allergy seasons growing from year to year, anticipating timing of clinical trials can be difficult.

Synteract draws on a breadth of experience managing diverse allergic disease studies internationally to give sponsors greater options when it comes to site and patient selection, study timing and trial length. We also draw on expertise in clinical trials for drugs to help cystic fibrosis patients who may also be more susceptible to allergies and respiratory issues.

While every study is unique to us at Synteract, we apply accumulated knowledge and highly-coordinated strategy to every allergy-related clinical trial.


Contact Synteract

Tell us how to stay in touch with you: